Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1,3-thiazole Derivatives as Selective Adenosine A_3 Antagonists
スポンサーリンク
概要
- 論文の詳細を見る
To investigate the potency of an adenosine A_3 receptor (A_3AR) antagonist as an anti-asthmatic drug, a novel series of 4-phenyl-5-pyridyl-1,3-thiazole derivatives was synthesized and evaluated in human adenosine A_1, A_<2A> and A_3 receptor and rat adenosine A_3 receptor binding assays. From investigation of the SAR study, compound 7af was identified as a highly potent human and rat A_3AR antagonist. This compound inhibited IB-MECA-induced plasma protein extravasation in the skin of rats and showed good oral absorption. Also, compound 7af significantly inhibited antigen-induced hyper-responsiveness to acetylcholine in actively sensitized Brown Norway rats. These results show that 4-phenyl-5-pyridyl-1,3-thiazole derivatives are potential candidates to enable the evaluation of A_3AR antagonists. Further evaluation of this class of compounds may afford a novel anti-inflammatory agent such as an anti-asthmatic drug.
- 2008-08-01
著者
-
MIWATASHI Seiji
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
ARIKAWA Yasuyoshi
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
OHKAWA Shigenori
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
Kanzaki Naoyuki
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Kanzaki Naoyuki
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
MATSUMOTO Tatsumi
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
UGA Keiko
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
IMAI Yumi
Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
Uga Keiko
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
Imai Yumi
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
Miwatashi Seiji
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
Ohkawa Shigenori
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
Ohkawa Shigenori
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Arikawa Yasuyoshi
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
-
Matsumoto Tatsumi
Pharmaceutical Research Division Takeda Pharmaceutical Company Ltd.
関連論文
- The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases Including AIDS, Cancer and Rheumatoid Arthritis
- CXCR4 Antagonists Identified as Anti-Cancer-Metastatic Agents
- Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1, 3-thiazole Derivatives as p38 MAP Kinase Inhibitors
- Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1,3-thiazole Derivatives as Selective Adenosine A_3 Antagonists
- Orally Active CCR5 Antagonists as Anti-HIV-1 Agents : Synthesis and Biological Activity of 1-Benzothiepine 1, 1-Dioxide and 1-Benzazepine Derivatives Containing a Tertiary Amine Moiety
- Kinetic Resolutions of Indan Derivatives Using Bacteria(Microbiology & Fermentation Technology)
- Kinetic Resolution of an Indan Derivative Using Bacillus sp.SUI-12 : Synthesis of a Key Intermediate of the Melatonin Receptor Agonist TAK-375
- Orally Active CCR5 Antagonists as Anti-HIV-1 Agents 2 : Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N-Oxide Moiety
- Synthesis of 1-Benzothiepine and 1-Benzazepine Derivatives as Orally Active CCR5 Antagonists
- CCR5 Antagonists as Anti-HIV-1 Agents.1. Synthesis and Biological Evaluation of 5-Oxopyrrolidine-3-carboxamide Derivatives